Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve 1. To consider and approve ....
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has scheduled a Board Meeting on Wednesday, 28th May 2025 at 4:30 PM at its corporate office in New Delhi. The key agenda item is to consider and approve the Audited Financial Results for the quarter and full financial year ended 31st March 2025. The Board will also consider appointing M/s Sanghi & Co., Chartered Accountants as the Internal Auditor of the Company for FY 2025-26. As per insider trading regulations, the trading window for directors, officers, designated employees and their relatives is already closed and will remain closed till 30th May 2025. The filing is submitted under SEBI LODR Regulations 29 and 33.
This is a routine pre-results announcement, not a material event in itself. Investors should look out for the actual Q4 and FY25 audited numbers, which are likely to be released on or shortly after 28th May 2025. No new financial data, dividend, or corporate action is being disclosed at this stage.